| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Revenue | — | — | — | — | — | — | — | — |
| Cost of Revenue | $0.2B | $0.3B | $0.2B | $0.2B | $0.1B | $0.1B | $0.1B | $0.1B |
| Gross Profit | — | — | — | — | — | — | — | — |
| R&D Expense | — | — | — | — | — | — | — | — |
| SG&A Expense | — | — | — | — | — | — | — | — |
| Operating Income | — | — | — | — | — | — | — | — |
| Net Income | $0.4B | $0.2B | $0.1B | $0.4B | $0.4B | $0.2B | $0.0B | $0.0B |
| EPS (Basic) | $11.79 | $5.02 | $2.45 | $10.83 | $10.20 | — | — | — |
| EPS (Diluted) | $11.79 | $5.02 | $2.45 | $10.83 | $10.20 | — | — | — |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Total Assets | $14.1B | $13.8B | $16.7B | $19.4B | $21.7B | $22.6B | $23.7B | $25.2B |
| Current Assets | — | — | — | — | — | — | — | — |
| Cash & Equivalents | $0.3B | $0.2B | $0.2B | $0.1B | $0.1B | $0.1B | $0.1B | $0.1B |
| Total Liabilities | $10.5B | $10.5B | $13.5B | $16.2B | $18.7B | $20.0B | $21.3B | $22.9B |
| Current Liabilities | — | — | — | — | — | — | — | — |
| Stockholders' Equity | $3.7B | $3.3B | $3.3B | $3.2B | $3.0B | $2.6B | $2.4B | — |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | $0.4B | $0.7B | $0.4B | $0.7B | $0.5B | $0.2B | $0.3B | $0.3B |
| Investing Cash Flow | $0.4B | $2.4B | $1.9B | $2.3B | $1.2B | $0.6B | $1.5B | $-0.7B |
| Capital Expenditures | $0.0B | $0.0B | $0.1B | $0.1B | $0.1B | $0.1B | $0.1B | $0.1B |
| Financing Cash Flow | $-0.7B | $-3.2B | $-2.7B | $-2.8B | $-1.5B | $-1.1B | $-1.8B | $0.7B |